Topics

Glioblastoma | Treatment | Chemotherapy | Temozolomide | Thrombocytopenia

Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Thrombocytopenia

van Hout L, Borgo AD, Grun N, Schuur M, Broen MPG, Westerman BA, Bartelink I, Vandertop WP, Lissenberg-Witte BI, Kouwenhoven MCM.
Severe temozolomide-induced thrombocytopenia is linked to increased healthcare utilization in glioblastoma and disproportionally impacts female patients.
Neurooncol Pract. 2025 Jan 22;12(4):678-690. doi: 10.1093/nop/npaf013. PMID: 40814424. Observational study. ˍ AI Overview